What are the ICD‑11 criteria (code HA60) for diagnosing Gender Incongruence in adolescents and adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-11 Gender Incongruence Criteria (Code HA60)

Gender Incongruence in ICD-11 is characterized by a marked and persistent incongruence between an individual's experienced gender and the assigned sex, which often leads to a desire to transition, in order to live and be accepted as a person of the experienced gender. 1

Core Diagnostic Features

The ICD-11 represents a fundamental shift from previous classifications by moving Gender Incongruence out of the mental disorders chapter into a new chapter on "Conditions Related to Sexual Health." 2, 3 This reflects the current understanding that gender diversity is not a mental illness but rather a health condition requiring medical support.

Key Diagnostic Elements

For adolescents and adults (HA60), the diagnosis requires:

  • Marked incongruence between experienced/expressed gender and assigned sex
  • Persistent pattern - the incongruence must be present for several months (though the exact duration remains debated in clinical practice) 4
  • Desire to transition - typically includes wanting to live and be accepted as a person of the experienced gender
  • May involve desire for medical interventions (hormones, surgery) to align physical characteristics with experienced gender

Critical Distinction from Previous Classifications

The distress criterion has been removed. 5 Unlike ICD-10's "Transsexualism" or DSM-5's "Gender Dysphoria," ICD-11 does not require psychological distress for diagnosis. This is crucial because:

  • Gender incongruence itself is the condition, not the distress it may cause
  • Distress (gender dysphoria) is not universally present in transgender individuals 1
  • Access to gender-affirming care should not depend on demonstrating suffering

What ICD-11 Does NOT Require

  • No minimum 2-year duration (unlike ICD-10 Transsexualism criteria) 6
  • No requirement for clinically significant distress or functional impairment
  • No exclusion for intersex conditions (this has been removed)
  • No specification of sexual orientation (completely eliminated from classification)

Clinical Application

The diagnosis should be straightforward when an individual presents with:

  1. Clear statement of gender identity differing from assigned sex
  2. Consistent pattern over time (several months minimum)
  3. Desire for social and/or medical transition

Common pitfall: Do not conflate gender expression with gender identity. An individual may have gender incongruence without conforming to stereotypical gender expressions. 7

Important consideration: The ICD-11 criteria are intentionally less restrictive than previous versions to reduce barriers to care while maintaining diagnostic validity. 4, 5 Studies show interrater reliability of 65-79% for adolescent/adult diagnoses, comparable to or better than previous classification systems.

Practical Implications

The reclassification aims to:

  • Reduce stigma associated with psychiatric diagnosis
  • Maintain access to healthcare and insurance coverage
  • Facilitate gender-affirming treatments that improve quality of life and reduce depression and suicidality 1

Healthcare providers should use this diagnosis to enable access to gender-affirming care, not as a gatekeeping mechanism. The focus is on supporting the individual's gender identity journey rather than pathologizing their experience. 8, 3

References

Guideline

endocrine treatment of transsexual persons: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.